BofA Securities Sees Trading Opportunity in Regeneron Pharma (REGN) Ahead of ASH Presentation
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham reiterated a $625.00 price target on Regeneron Pharma (NASDAQ: REGN) expecting shares to trade up ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
